Published in J Virol on January 01, 2006
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Herpes virus fusion and entry: a story with many characters. Viruses (2012) 2.05
Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest (2011) 1.82
HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A (2008) 1.79
Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol (2008) 1.64
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol (2009) 1.63
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine (2008) 1.61
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol (2010) 1.51
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 1.50
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types. Proc Natl Acad Sci U S A (2008) 1.26
Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci U S A (2008) 1.25
Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol (2011) 1.23
Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells. Proc Natl Acad Sci U S A (2007) 1.23
Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol (2009) 1.19
Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes. Proc Natl Acad Sci U S A (2015) 1.17
Low pH-induced conformational change in herpes simplex virus glycoprotein B. J Virol (2010) 1.16
Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS One (2012) 1.14
Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism. J Virol (2015) 1.13
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine (2011) 1.13
Human cytomegalovirus entry into cells. Curr Opin Virol (2012) 1.12
Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol (2013) 1.11
PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog (2012) 1.10
Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflammation (2012) 1.10
Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells. J Virol (2007) 1.07
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J Virol (2011) 1.07
BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog (2011) 1.04
Glycoprotein B switches conformation during murid herpesvirus 4 entry. J Gen Virol (2008) 1.03
A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism. Proc Natl Acad Sci U S A (2015) 1.02
Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys. J Virol (2011) 1.02
HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. Virology (2012) 1.01
An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation. J Virol (2013) 1.00
Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol (2006) 1.00
Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J Virol (2011) 1.00
The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS One (2014) 0.99
Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein. MBio (2013) 0.98
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. PLoS Pathog (2014) 0.97
Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells. J Virol (2013) 0.97
Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol (2011) 0.96
Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells. J Virol (2015) 0.95
Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity. J Virol (2011) 0.95
Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques. J Virol (2010) 0.95
The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. J Virol (2009) 0.95
The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes. PLoS Pathog (2013) 0.95
Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination. J Leukoc Biol (2012) 0.94
Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology (2007) 0.93
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109. Proc Natl Acad Sci U S A (2014) 0.93
Human cytomegalovirus pUL78 G protein-coupled receptor homologue is required for timely cell entry in epithelial cells but not fibroblasts. J Virol (2012) 0.91
Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies. Clin Vaccine Immunol (2013) 0.89
HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex. Viruses (2014) 0.89
Charge cluster-to-alanine scanning of UL128 for fine tuning of the endothelial cell tropism of human cytomegalovirus. J Virol (2008) 0.88
The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex. PLoS Pathog (2013) 0.88
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection. J Virol (2015) 0.87
Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies. PLoS Pathog (2015) 0.87
An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Clin Dev Immunol (2013) 0.86
Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody. PLoS Pathog (2014) 0.86
Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton. J Virol (2009) 0.86
The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol (2012) 0.85
Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets (2011) 0.85
Human cytomegalovirus: taking the strain. Med Microbiol Immunol (2015) 0.84
Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133. Viruses (2014) 0.84
Models of vertical cytomegalovirus (CMV) transmission and pathogenesis. Semin Immunopathol (2014) 0.84
Cytomegalovirus vaccines and methods of production (WO20009049138): the emerging recognition of the importance of virus neutralization at the epithelial/endothelial interface. Expert Opin Ther Pat (2010) 0.84
Role of the UL45 protein in herpes simplex virus entry via low pH-dependent endocytosis and its relationship to the conformation and function of glycoprotein B. Virus Res (2010) 0.84
Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection. J Virol (2010) 0.84
Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model. Virol J (2011) 0.83
Contributions of herpes simplex virus 1 envelope proteins to entry by endocytosis. J Virol (2013) 0.83
Mutational mapping of pUL131A of human cytomegalovirus emphasizes its central role for endothelial cell tropism. J Virol (2011) 0.82
The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97. J Virol (2013) 0.82
Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication. PLoS Pathog (2013) 0.82
Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol (2011) 0.81
gH/gL supercomplexes at early stages of herpesvirus entry. Curr Opin Virol (2016) 0.81
Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus. J Virol (2013) 0.81
Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus. J Virol (2014) 0.81
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer. Nat Microbiol (2016) 0.80
Herpesvirus gB: A Finely Tuned Fusion Machine. Viruses (2015) 0.80
Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol (2014) 0.80
Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans. J Exp Med (2017) 0.79
Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro. J Virol (2016) 0.79
RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection. J Virol (2010) 0.79
Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL. J Virol (2015) 0.78
Herpesviruses and intermediate filaments: close encounters with the third type. Viruses (2011) 0.78
Inactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial Cells. J Virol (2015) 0.77
Polyethylene glycol-mediated fusion of herpes simplex type 1 virions with the plasma membrane of cells that support endocytic entry. Virol J (2015) 0.77
Preventing Congenital Cytomegalovirus Infection: Protection to a 'T'. Trends Microbiol (2016) 0.77
Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions. PLoS Pathog (2016) 0.77
The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. J Gen Virol (2016) 0.77
Tetraspanin CD151 Promotes Initial Events in Human Cytomegalovirus Infection. J Virol (2016) 0.77
Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis. Med Microbiol Immunol (2012) 0.77
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway. Microbiol Mol Biol Rev (2016) 0.76
A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus. PLoS Pathog (2016) 0.76
Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection. J Virol (2016) 0.76
Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1. Virology (2013) 0.76
An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A (2000) 17.30
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics (2001) 15.03
On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol (1980) 11.05
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A (1988) 10.77
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol (1988) 7.80
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol (1979) 6.72
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol (1988) 5.84
Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol (1982) 5.21
Herpesvirus entry: an update. J Virol (2003) 5.19
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol (1992) 5.18
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol (1993) 4.67
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med (2002) 4.33
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus. J Virol (1988) 4.11
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest (2001) 3.64
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology (1993) 3.42
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J Virol (1988) 3.33
Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol (2003) 3.14
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol (1991) 3.00
Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol (2005) 2.77
Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature (2003) 2.77
Directed egress of animal viruses promotes cell-to-cell spread. J Virol (2002) 2.72
Infectious cell entry mechanism of influenza virus. J Virol (1982) 2.41
Endocytosis of influenza viruses. Microbes Infect (2004) 2.38
Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology (1992) 2.29
Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway. Virus Res (1991) 2.29
Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A (2004) 2.19
Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol (2005) 2.19
Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol (2001) 2.18
Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J Virol (2004) 2.17
Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat Med (2005) 2.15
Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol (1992) 2.07
Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J Virol (2005) 2.07
The human cytomegalovirus. Pharmacol Ther (2003) 2.06
Do pathogens accelerate atherosclerosis? J Nutr (2001) 1.91
A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol (2001) 1.79
Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol (1993) 1.77
Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol (1995) 1.77
Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res (1996) 1.72
Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol (1966) 1.71
Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol (2004) 1.66
Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol (2000) 1.55
Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol (2004) 1.48
Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J Virol (2003) 1.43
Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion. J Virol (2005) 1.43
Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol (2003) 1.39
Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest Ophthalmol Vis Sci (1999) 1.36
Poly(ethylene glycol) (PEG)-mediated fusion between pure lipid bilayers: a mechanism in common with viral fusion and secretory vesicle release? Mol Membr Biol (2000) 1.35
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
A herpes simplex virus 1 US11-expressing cell line is resistant to herpes simplex virus infection at a step in viral entry mediated by glycoprotein D. J Virol (1994) 1.29
Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol (2002) 1.25
Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol (1999) 1.23
Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein. Proc Natl Acad Sci U S A (2005) 1.21
Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J Gen Virol (2003) 1.20
Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol (2002) 1.20
Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread. J Virol (2000) 1.17
Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169. Virus Res (1998) 0.97
Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts. J Virol (2005) 0.91
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature (2011) 9.30
Duration of antiviral immunity after smallpox vaccination. Nat Med (2003) 7.39
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med (2009) 7.33
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med (2005) 7.18
Preventing the return of fear in humans using reconsolidation update mechanisms. Nature (2009) 5.82
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science (2010) 3.31
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science (2013) 3.27
Immune clearance of highly pathogenic SIV infection. Nature (2013) 3.15
Differential regulation of cell motility and invasion by FAK. J Cell Biol (2003) 3.15
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood (2006) 2.43
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood (2012) 2.38
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood (2010) 2.25
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med (2003) 2.20
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood (2006) 2.13
Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane. Proc Natl Acad Sci U S A (2007) 2.07
West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol (2007) 1.86
A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog (2010) 1.82
HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A (2008) 1.79
Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe (2010) 1.77
Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A (2012) 1.77
Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol (2008) 1.64
Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant (2005) 1.63
Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm. J Virol (2003) 1.63
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol (2009) 1.63
Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population. PLoS Pathog (2013) 1.53
Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol Dis (2007) 1.52
Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol (2002) 1.52
Cytoplasmic residues of herpes simplex virus glycoprotein gE required for secondary envelopment and binding of tegument proteins VP22 and UL11 to gE and gD. J Virol (2006) 1.46
Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J Virol (2006) 1.39
The Src family kinase c-Yes is required for maturation of West Nile virus particles. J Virol (2005) 1.39
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res (2010) 1.39
Investigation of the origin of tensile stress-induced rate enhancements in the photochemical degradation of polymers. J Am Chem Soc (2004) 1.39
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A (2005) 1.38
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood (2010) 1.36
Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J Virol (2008) 1.36
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood (2013) 1.35
High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol (2010) 1.33
The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors. J Virol (2005) 1.31
A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog (2011) 1.30
FAK promotes organization of fibronectin matrix and fibrillar adhesions. J Cell Sci (2003) 1.28
Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J Virol (2006) 1.28
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol (2004) 1.28
Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase. J Virol (2009) 1.27
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med (2005) 1.26
Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol (2002) 1.25
Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids. J Virol (2004) 1.24
A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. PLoS Negl Trop Dis (2011) 1.23
Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol (2008) 1.23
Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol (2011) 1.23
West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol (2008) 1.19
Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res (2008) 1.19
Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol (2009) 1.19
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol (2003) 1.18
Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread. J Virol (2003) 1.17
Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation. J Virol (2006) 1.17
The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins. J Biol Chem (2006) 1.17
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells. Blood (2013) 1.16
Viral inhibition of MHC class II antigen presentation. Trends Immunol (2003) 1.16
Human cytomegalovirus chemokine receptor US28-induced smooth muscle cell migration is mediated by focal adhesion kinase and Src. J Biol Chem (2003) 1.15
Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol (2007) 1.13
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine (2011) 1.13
Human cytomegalovirus entry into cells. Curr Opin Virol (2012) 1.12
Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J Virol (2004) 1.11
Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol (2006) 1.10
PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog (2012) 1.10
Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation (2002) 1.08
Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol (2009) 1.08
Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J Neurosci Res (2003) 1.08
Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells. J Virol (2002) 1.07
A herpes simplex virus gD-YFP fusion glycoprotein is transported separately from viral capsids in neuronal axons. J Virol (2007) 1.05
Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J Virol (2007) 1.05
BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog (2011) 1.04
West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol (2009) 1.03
Inhibition of TCR signaling by herpes simplex virus. J Immunol (2006) 1.03
Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol (2011) 1.02
HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. Virology (2012) 1.01
Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J Virol (2002) 1.01
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol (2011) 1.01
Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol (2006) 1.00
P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection. PLoS Pathog (2009) 0.99
Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. J Virol (2011) 0.98